April 2, 2025. That was the day Trump signed the sweeping executive order he branded "Liberation Day" — a broad tariff structure targeting dozens of countries that the administration framed as the beginning of a new era in American trade policy. One year later, the Supreme Court struck it down 6-3, finding the administration had overstepped the statutory authority granted to the executive on tariffs. The original Liberation Day tariffs are gone.
The response to that setback was not a policy retreat. It was a more targeted rerun. On the first anniversary of Liberation Day, Trump signed new tariffs — this time on pharmaceuticals and on steel and aluminum imports. These are narrower, built on more defensible legal ground, and harder to challenge as overreach than the sweeping country-by-country framework that the Court killed. Whether that legal tightening holds up is for the courts to decide. But the intent is the same: use import barriers to reshape supply chains and force domestic production.
What the Pharmaceutical Tariffs Mean
The pharma tariffs are the more consequential of the two. The United States produces remarkably little of its own active pharmaceutical ingredients — the actual chemistry behind branded and generic drugs. India and China dominate global API production, and the supply-chain vulnerabilities exposed during COVID never fully resolved. Trump's argument is that tariffing pharmaceutical imports creates pressure to onshore that manufacturing. The counterargument is that pharmaceutical supply chains take years to rebuild, and consumers pay the price in the meantime through higher drug costs passed through by manufacturers.
The steel and aluminum tariffs are an expansion of what's been in place in various forms since the first Trump administration. They're popular with domestic producers, they're contested by trading partners, and they've become a recurring feature of U.S. trade policy regardless of who sits in the Oval Office.
The Supreme Court's ruling on the original Liberation Day tariffs established that the executive can't just invent broad tariff authority. But it didn't eliminate the president's ability to use existing statutory tools more precisely. The anniversary celebration, such as it is, looks a lot like the original event — just written in smaller, harder-to-erase handwriting. The global trading system is watching to see if the sequel sticks where the original didn't.